Topics

Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Erectile Dysfunction, Date of authorisation: 21/11/2014, Revision: 8, Status: Authorised

06:02 EDT 16 Jul 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Erectile Dysfunction, Date of authorisation: 21/11/2014, Revision: 8, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Erectile Dysfunction, Date of authorisation: 21/11/2014, Revision: 8, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Tadalafil Mylan, tadalafil, Erectile Dysfunction, Date of authorisation: 21/11/2014, Revision: 8, Status: Authorised"

Quick Search

Relevant Topic

Erectile Dysfunction
Erectile dysfunction (ED or impotence) is the inability to get and maintain an erection that is sufficient for satisfactory sexual intercourse, and affects half of all men between the ages of 40 to 70. The causes of ED can be both physical and psycholo...